Montreux Healthcare Consultancy Ltd - Accounts to registrar (filleted) - small 23.2.5

Montreux Healthcare Consultancy Ltd - Accounts to registrar (filleted) - small 23.2.5


IRIS Accounts Production v23.3.1.45 12896356 Board of Directors 1.1.22 31.12.22 31.12.22 false true false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128963562021-12-31128963562022-12-31128963562022-01-012022-12-31128963562020-09-21128963562020-09-222021-12-31128963562021-12-3112896356ns10:Originalns15:EnglandWales2022-01-012022-12-3112896356ns14:PoundSterlingns10:Original2022-01-012022-12-3112896356ns10:Originalns10:Director12022-01-012022-12-3112896356ns10:Original2022-01-012022-12-3112896356ns10:Original2022-12-3112896356ns10:Originalns10:PrivateLimitedCompanyLtd2022-01-012022-12-3112896356ns10:Originalns10:SmallEntities2022-01-012022-12-3112896356ns10:Originalns10:AuditExempt-NoAccountantsReport2022-01-012022-12-3112896356ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-01-012022-12-3112896356ns10:SmallCompaniesRegimeForAccountsns10:Original2022-01-012022-12-3112896356ns10:Originalns10:FullAccounts2022-01-012022-12-3112896356ns10:Originalns10:OrdinaryShareClass12022-01-012022-12-3112896356ns10:Originalns10:Director22022-01-012022-12-3112896356ns10:Originalns10:RegisteredOffice2022-01-012022-12-3112896356ns10:Original2021-12-3112896356ns10:Originalns5:CurrentFinancialInstruments2022-12-3112896356ns10:Originalns5:CurrentFinancialInstruments2021-12-3112896356ns5:ShareCapitalns10:Original2022-12-3112896356ns5:ShareCapitalns10:Original2021-12-3112896356ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3112896356ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-12-3112896356ns10:Original2020-09-222021-12-3112896356ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3112896356ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2021-12-3112896356ns10:Originalns10:OrdinaryShareClass12022-12-3112896356ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-12-3112896356ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-01-012022-12-31
REGISTERED NUMBER: 12896356 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2022

FOR

MONTREUX HEALTHCARE CONSULTANCY LTD

MONTREUX HEALTHCARE CONSULTANCY LTD (REGISTERED NUMBER: 12896356)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MONTREUX HEALTHCARE CONSULTANCY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2022







DIRECTORS: Ms A M Collman
Miss K King





REGISTERED OFFICE: Thameside House
Hurst Road
East Molesey
KT8 9AY





REGISTERED NUMBER: 12896356 (England and Wales)





ACCOUNTANTS: Crowe U.K. LLP
Riverside House
40-46 High Street
Maidstone
Kent
ME14 1JH

MONTREUX HEALTHCARE CONSULTANCY LTD (REGISTERED NUMBER: 12896356)

BALANCE SHEET
31 DECEMBER 2022

2022 2021
Notes £    £   
CURRENT ASSETS
Debtors 4 55,253 92,540

CREDITORS
Amounts falling due within one year 5 47,281 53,938
NET CURRENT ASSETS 7,972 38,602
TOTAL ASSETS LESS CURRENT
LIABILITIES

7,972

38,602

CAPITAL AND RESERVES
Called up share capital 6 1 1
Retained earnings 7 7,971 38,601
SHAREHOLDERS' FUNDS 7,972 38,602

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 December 2023 and were signed on its behalf by:





Miss K King - Director


MONTREUX HEALTHCARE CONSULTANCY LTD (REGISTERED NUMBER: 12896356)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022


1. STATUTORY INFORMATION

Montreux Healthcare Consultancy Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
Accounting standards require the directors to consider the appropriateness of the going concern basis when preparing the financial statements. The directors confirm that they consider that the going concern basis remains appropriate. The directors believe that the company has sufficient resources to continue in operational existence for the foreseeable future. The directors believe this to be the case as the company has the support of the directors and positive reserves. Thus they continue to adopt the going concern basis of accounting in preparing the annual financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Debtors
Short term debtors are measured at transaction prices, less any impairment.

Creditors
Short term creditors are measured at the transaction price.

Financial Instruments
The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

MONTREUX HEALTHCARE CONSULTANCY LTD (REGISTERED NUMBER: 12896356)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2022


2. ACCOUNTING POLICIES - continued

Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with no significant risk of change in value.

FINANCIAL REPORTING STANDARD 102 - REDUCED DISCLOSURE EXEMPTIONS

The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
- the requirements of Section 7 Statement of Cash Flows;
- the requirements of Section 3 Financial Statement Presentation paragraph 3.17 (d);
- the requirements of Section 11 Financial Instruments paragraphs 11.39 to 11.48A;
- the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.29;
- the requirements of Section 26 Share-based Payment paragraphs 26.18(b), 26.19 to 26.21 and 26.23;
- the requirements of Section 33 Related Party Disclosures paragraph 33.7.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2021 - 2 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Other debtors 48,067 92,539
Tax 7,185 -
Called up share capital not paid 1 1
55,253 92,540

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade creditors 3,264 1,075
Corporation tax - 9,055
VAT 41,667 41,667
Accruals and deferred income 2,350 2,141
47,281 53,938

6. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 2022 2021
value: £    £   
100 Ordinary £0.01 1 1

7. RESERVES
Retained
earnings
£   

At 1 January 2022 38,601
Deficit for the year (30,630 )
At 31 December 2022 7,971

MONTREUX HEALTHCARE CONSULTANCY LTD (REGISTERED NUMBER: 12896356)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2022


8. PENSION COMMITMENTS

The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charged represents contributions payable by the company to the fund and amounted to £675 (2021: £4,600). At the balance sheet date, outstanding contributions amounted to £nil (2021: £nil).

9. RELATED PARTY DISCLOSURES

Montreux Group Overseas Limited
Common control

During the year the company made loan advances to Montreux Group Overseas Limited, as at 31 December 2022 the net balance outstanding from Montreux Group Overseas Limited was £48,067 (2021: £92,539). The loan is interest free and repayable on demand.

10. ULTIMATE CONTROLLING PARTY

As at the balance sheet date O S Harris is the ultimate controlling party.